Literature DB >> 16127155

Membrane rafts segregate pro- from anti-apoptotic insulin-like growth factor-I receptor signaling in colon carcinoma cells stimulated by members of the tumor necrosis factor superfamily.

Maryse Remacle-Bonnet1, Françoise Garrouste, Gilbert Baillat, Frédéric Andre, Jacques Marvaldi, Gilbert Pommier.   

Abstract

In the tumor microenvironment, autocrine/paracrine loops of insulin-like growth factors (IGFs) contribute to cancer cell survival. However, we report here that IGF-I can send contradictory signals that interfere with cell death induced by different ligands of the tumor necrosis factor (TNF) superfamily. IGF-I protected human colon carcinoma cells from TNF-alpha-induced apoptosis, but it enhanced the apoptotic response to anti-Fas antibody and TNF-related apoptosis inducing ligand stimulation. This proapoptotic effect of IGF-I, observed in several but not all tested colon cancer cell lines, was mediated via the phosphatidylinositol 3'-kinase (PI3K)/Akt pathway. Furthermore, IGF-I receptors (IGF-IR) were located in and out of membrane lipid rafts and were tyrosine autophosphorylated in response to IGF-I. However, disruption of rafts by acute cholesterol depletion shifted IGF-IR to non-raft domains, abolished the IGF-I-mediated proapoptotic effect, and inhibited the IGF-I-dependent IRS-1 and Akt recruitment into and phosphorylation/activation within lipid rafts. Replenishing cell membranes with cholesterol reversed these effects. Activation of extracellular-regulated kinase-1/2 and p38 mitogen-activated protein kinase, which convey the IGF-I anti-apoptotic effect, occurred independently of lipid rafts. Thus, we propose that segregation of IGF-IR in and out of lipid rafts may dynamically regulate the pro- and anti-apoptotic effects of IGF-I on apoptosis induced by TNF superfamily members.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16127155      PMCID: PMC1698735          DOI: 10.1016/S0002-9440(10)62049-4

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  64 in total

Review 1.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

Review 2.  The IGF-1 receptor in cancer biology.

Authors:  Renato Baserga; Francesca Peruzzi; Krysztof Reiss
Journal:  Int J Cancer       Date:  2003-12-20       Impact factor: 7.396

3.  Resistance of cell membranes to different detergents.

Authors:  Sebastian Schuck; Masanori Honsho; Kim Ekroos; Andrej Shevchenko; Kai Simons
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-29       Impact factor: 11.205

Review 4.  Signalling pathways of the TNF superfamily: a double-edged sword.

Authors:  Bharat B Aggarwal
Journal:  Nat Rev Immunol       Date:  2003-09       Impact factor: 53.106

5.  Caveolin-induced activation of the phosphatidylinositol 3-kinase/Akt pathway increases arsenite cytotoxicity.

Authors:  Sonsoles Shack; Xian-Tao Wang; Gertrude C Kokkonen; Myriam Gorospe; Dan L Longo; Nikki J Holbrook
Journal:  Mol Cell Biol       Date:  2003-04       Impact factor: 4.272

6.  Lipid rafts/caveolae are essential for insulin-like growth factor-1 receptor signaling during 3T3-L1 preadipocyte differentiation induction.

Authors:  Hairong Huo; Xuemin Guo; Shangyu Hong; Manrong Jiang; Xinyuan Liu; Kan Liao
Journal:  J Biol Chem       Date:  2003-01-21       Impact factor: 5.157

7.  IL-4 augments anisomycin-induced p38 activation via Akt pathway in a follicular dendritic cell (FDC)-like line.

Authors:  Hyang-Mi Lee; Hyung-Sung Jin; Jae-Won Park; Sun-Mi Park; Hye-Kyung Jeon; Tae H Lee
Journal:  FEBS Lett       Date:  2003-08-14       Impact factor: 4.124

Review 8.  Tumour necrosis factor alpha: a potential target for the therapy of solid tumours.

Authors:  Peter W Szlosarek; Frances R Balkwill
Journal:  Lancet Oncol       Date:  2003-09       Impact factor: 41.316

9.  Type 1 insulin-like growth factor receptor (IGF-IR) signaling inhibits apoptosis signal-regulating kinase 1 (ASK1).

Authors:  Veronica Galvan; Anna Logvinova; Sabina Sperandio; Hidenori Ichijo; Dale E Bredesen
Journal:  J Biol Chem       Date:  2003-01-28       Impact factor: 5.157

Review 10.  Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.

Authors:  Eva Surmacz
Journal:  Oncogene       Date:  2003-09-29       Impact factor: 9.867

View more
  24 in total

Review 1.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy: Thematic Review Series: Biology of Lipid Rafts.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-11-07       Impact factor: 5.922

2.  Proinflammatory actions of visfatin/nicotinamide phosphoribosyltransferase (Nampt) involve regulation of insulin signaling pathway and Nampt enzymatic activity.

Authors:  Claire Jacques; Martin Holzenberger; Zvezdana Mladenovic; Colette Salvat; Emilie Pecchi; Francis Berenbaum; Marjolaine Gosset
Journal:  J Biol Chem       Date:  2012-03-07       Impact factor: 5.157

Review 3.  Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy.

Authors:  Faustino Mollinedo; Consuelo Gajate
Journal:  J Lipid Res       Date:  2020-01-27       Impact factor: 5.922

4.  Inhibition of IGF-1R-dependent PI3K activation sensitizes colon cancer cells specifically to DR5-mediated apoptosis but not to rhTRAIL.

Authors:  Bodvael Pennarun; Jan H Kleibeuker; Tjitske Oenema; Janet H Stegehuis; Elisabeth G E de Vries; Steven de Jong
Journal:  Cell Oncol (Dordr)       Date:  2011-04-30       Impact factor: 6.730

5.  Systematic analysis of off-target effects in an RNAi screen reveals microRNAs affecting sensitivity to TRAIL-induced apoptosis.

Authors:  Ian Sudbery; Anton J Enright; Andrew G Fraser; Ian Dunham
Journal:  BMC Genomics       Date:  2010-03-15       Impact factor: 3.969

6.  Insulin augments gonadotropin-releasing hormone induction of translation in LbetaT2 cells.

Authors:  Amy M Navratil; Hyunjin Song; Jeniffer B Hernandez; Brian D Cherrington; Sharon J Santos; Janine M Low; Minh-Ha T Do; Mark A Lawson
Journal:  Mol Cell Endocrinol       Date:  2009-07-24       Impact factor: 4.102

7.  Conjugated linoleic acid decreases mcf-7 human breast cancer cell growth and insulin-like growth factor-1 receptor levels.

Authors:  Danielle L Amarù; Catherine J Field
Journal:  Lipids       Date:  2009-03-06       Impact factor: 1.880

8.  IGF-I activates caspases 3/7, 8 and 9 but does not induce cell death in colorectal cancer cells.

Authors:  Shi Yu Yang; Capucine Bolvin; Kevin M Sales; Barry Fuller; Alexander M Seifalian; Marc C Winslet
Journal:  BMC Cancer       Date:  2009-05-21       Impact factor: 4.430

9.  Targeting receptor tyrosine kinases for chemoprevention by green tea catechin, EGCG.

Authors:  Masahito Shimizu; Yohei Shirakami; Hisataka Moriwaki
Journal:  Int J Mol Sci       Date:  2008-06-20       Impact factor: 6.208

10.  Gene expression analysis of biological systems driving an organotypic model of endometrial carcinogenesis and chemoprevention.

Authors:  Doris M Benbrook; Stan Lightfoot; James Ranger-Moore; Tongzu Liu; Shylet Chengedza; William L Berry; Igor Dozmorov
Journal:  Gene Regul Syst Bio       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.